Inogen (INGN) Interest & Investment Income (2013 - 2026)
Inogen's (INGN) quarterly Interest & Investment Income came in at $861000.0 in Q2 2026, down 23.33% year-over-year from $1.1 million in Q2 2025, and down 2.16% quarter-over-quarter from $880000.0 in Q1 2026.
Analysis
Inogen (INGN) Interest & Investment Income (2013 - 2026) Analysis & Trends
Inogen (INGN) has reported Interest & Investment Income for 14 consecutive years, with $861000.0 the latest figure, recorded in Q2 2026.
- On a quarterly basis, Interest & Investment Income fell 23.33% year-over-year to $861000.0 in Q2 2026; TTM through Jun 2026 was $4.0 million, a 13.72% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, down 15.51% from the prior year.
- Interest & Investment Income was $861000.0 for Q2 2026 at Inogen, down from $880000.0 in the prior quarter.
- Over five years, Interest & Investment Income peaked at $1.8 million in Q3 2023 and troughed at $29000.0 in Q1 2022.
- A 5-year average of $1.2 million and a median of $1.1 million in 2025 frame the typical range for Interest & Investment Income.
- The widest YoY moves for Interest & Investment Income: up 7695.45% in 2022, down 49.12% in 2022.
- Over 5 years, Interest & Investment Income stood at $1.7 million in 2022, then decreased by 6.59% to $1.6 million in 2023, then fell by 11.8% to $1.4 million in 2024, then fell by 17.69% to $1.2 million in 2025, then dropped by 25.97% to $861000.0 in 2026.
- The last three Interest & Investment Income figures came in at $861000.0 (Q2 2026), $880000.0 (Q1 2026), and $1.2 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.14 Bn | 177.54 Bn | 7.27 Bn | 52.00 Mn |
| 2 | Intuitive Surgical | 125.03 Bn | 119.81 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.95 Bn | 109.13 Bn | 6.34 Bn | - |
| 4 | Stryker | 105.45 Bn | 101.97 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 66.16 Bn | 65.62 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.54 Bn | 45.29 Bn | 1.35 Bn | 30.00 Mn |
| 7 | Alcon | 33.69 Bn | 32.23 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.03 Bn | 30.08 Bn | 830.00 Mn | - |
| 9 | Steris | 21.01 Bn | 20.53 Bn | 684.20 Mn | - |
| 10 | Inogen | 142.66 Mn | 37.12 Mn | 43.27 Mn | 861,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 861,000.00 |
| Mar 31, 2026 | 880,000.00 |
| Dec 31, 2025 | 1.16 Mn |
| Sep 30, 2025 | 1.07 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | 1.03 Mn |
| Dec 31, 2024 | 1.41 Mn |
| Sep 30, 2024 | 1.04 Mn |
| Jun 30, 2024 | 1.33 Mn |
| Mar 31, 2024 | 1.40 Mn |
| Dec 31, 2023 | 1.60 Mn |
| Sep 30, 2023 | 1.80 Mn |
| Jun 30, 2023 | 1.65 Mn |
| Mar 31, 2023 | 1.53 Mn |
| Dec 31, 2022 | 1.72 Mn |
| Sep 30, 2022 | 868,000.00 |
| Jun 30, 2022 | 225,000.00 |
| Mar 31, 2022 | 29,000.00 |
| Dec 31, 2021 | 22,000.00 |
| Sep 30, 2021 | 21,000.00 |